{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:12:49Z","timestamp":1788876769923,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05126-2","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:35:11Z","timestamp":1782214511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IgA nephropathy shortly follwed by seroconversion of positive anti-GBM antibodies and rapid progressive glomerulonephritis in a Chinese boy: coincidental overlap or pathogenic link?"],"prefix":"10.1186","volume":"27","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"12","key":"5126_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2011.89","volume":"7","author":"Z Cui","year":"2011","unstructured":"Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol. 2011;7(12):697\u2013705.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5126_CR2","doi-asserted-by":"publisher","first-page":"103212","DOI":"10.1016\/j.autrev.2022.103212","volume":"22","author":"C Ponticelli","year":"2023","unstructured":"Ponticelli C, Calatroni M, Moroni G. Anti-glomerular basement membrane vasculitis. Autoimmun rev. 2023;22(1):103212.","journal-title":"Autoimmun rev"},{"issue":"1","key":"5126_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08860220500461195","volume":"28","author":"Z Cui","year":"2006","unstructured":"Cui Z, Zhao MH, Wang SX, Liu G, Zou WZ, Wang HY. Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis. Ren Fail. 2006;28(1):7\u201314.","journal-title":"Ren Fail"},{"issue":"3","key":"5126_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1681\/ASN.V83376","volume":"8","author":"T Hellmark","year":"1997","unstructured":"Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrology: JASN. 1997;8(3):376\u201385.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"5126_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66(4):1535\u201340.","journal-title":"Kidney Int"},{"issue":"3","key":"5126_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2009.07.015","volume":"55","author":"K O\u2019Connor","year":"2010","unstructured":"O\u2019Connor K, Fulcher D, Phoon RK. Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility. Am J kidney diseases: official J Natl Kidney Foundation. 2010;55(3):566\u20139.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"4","key":"5126_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ki.2013.364","volume":"85","author":"XY Jia","year":"2014","unstructured":"Jia XY, Hu SY, Chen JL, Qu Z, Liu G, Cui Z, Zhao MH. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int. 2014;85(4):945\u201352.","journal-title":"Kidney Int"},{"issue":"10","key":"5126_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1093\/ndt\/16.10.2082","volume":"16","author":"JT Kielstein","year":"2001","unstructured":"Kielstein JT, Helmchen U, Netzer KO, Weber M, Haller H, Floege J. Conversion of Goodpasture\u2019s syndrome into membranous glomerulonephritis. Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association. 2001;16(10):2082\u20135.","journal-title":"Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"5","key":"5126_CR9","first-page":"e39737","volume":"15","author":"T Matsuno","year":"2023","unstructured":"Matsuno T, Okumura T. Anti-glomerular Basement Membrane Disease After Diagnosis of Immunoglobulin A Nephropathy: A Case Report. Cureus. 2023;15(5):e39737.","journal-title":"Cureus"},{"issue":"3","key":"5126_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN. IgA Nephropathy: Core Curriculum 2021. Am J kidney diseases: official J Natl Kidney Foundation. 2021;78(3):429\u201341.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"1","key":"5126_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, Barratt J, Kramann R. IgA nephropathy. Nat reviews Disease primers. 2023;9(1):67.","journal-title":"Nat reviews Disease primers"},{"issue":"2","key":"5126_CR12","first-page":"629","volume":"118","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Investig. 2008;118(2):629\u201339.","journal-title":"J Clin Investig"},{"issue":"10","key":"5126_CR13","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrology: JASN. 2011;22(10):1795\u2013803.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"2","key":"5126_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, Gibson K, Haas M, Abdel-Hafez MA, Adragna M, et al. IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. 2025;40(2):533\u201369.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"5126_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.14227\/DT300423P224","volume":"30","author":"J Dressman","year":"2023","unstructured":"Dressman J. Comparative Dissolution of Budesonide from Four Commercially Available Products for Oral Administration: Implications for Interchangeablity. Dissolution Technol. 2023;30(4):224\u20139.","journal-title":"Dissolution Technol"},{"key":"5126_CR16","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.2147\/DDDT.S383138","volume":"18","author":"J Barratt","year":"2024","unstructured":"Barratt J, Kristensen J, Pedersen C, Jerling M. Insights on Nefecon((R)), a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Drug Des Devel Ther. 2024;18:3415\u201328.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"5126_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003088-200443120-00003","volume":"43","author":"S Edsb\u00e4cker","year":"2004","unstructured":"Edsb\u00e4cker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn\u2019s disease. Clin Pharmacokinet. 2004;43(12):803\u201321.","journal-title":"Clin Pharmacokinet"},{"issue":"10405","key":"5126_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(23)01554-4","volume":"402","author":"R Lafayette","year":"2023","unstructured":"Lafayette R, Kristensen J, Stone A, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Reich HN, et al. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402(10405):859\u201370.","journal-title":"Lancet"},{"issue":"7","key":"5126_CR19","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD. Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrology: CJASN. 2017;12(7):1162\u201372.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"4","key":"5126_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1681\/ASN.V641178","volume":"6","author":"R Kalluri","year":"1995","unstructured":"Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrology: JASN. 1995;6(4):1178\u201385.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"5126_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343\u201354.","journal-title":"N Engl J Med"},{"issue":"6","key":"5126_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2215\/CJN.09930911","volume":"7","author":"XY Jia","year":"2012","unstructured":"Jia XY, Cui Z, Yang R, Hu SY, Zhao MH. Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury. Clin J Am Soc Nephrology: CJASN. 2012;7(6):926\u201333.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"4","key":"5126_CR23","doi-asserted-by":"publisher","first-page":"e0123277","DOI":"10.1371\/journal.pone.0123277","volume":"10","author":"XY Jia","year":"2015","unstructured":"Jia XY, Cui Z, Li JN, Hu SY, Zhao MH. Identification of critical residues of linear B cell epitope on Goodpasture autoantigen. PLoS ONE. 2015;10(4):e0123277.","journal-title":"PLoS ONE"},{"issue":"6","key":"5126_CR24","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1046\/j.1523-1755.2003.00332.x","volume":"64","author":"L Chen","year":"2003","unstructured":"Chen L, Hellmark T, Wieslander J, Bolton WK. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats. Kidney Int. 2003;64(6):2108\u201320.","journal-title":"Kidney Int"},{"issue":"3","key":"5126_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ki.1995.347","volume":"48","author":"HY Lan","year":"1995","unstructured":"Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 1995;48(3):753\u201360.","journal-title":"Kidney Int"},{"issue":"2","key":"5126_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1523-1755.2001.060002614.x","volume":"60","author":"NM Isbel","year":"2001","unstructured":"Isbel NM, Hill PA, Foti R, Mu W, Hurst LA, Stambe C, Lan HY, Atkins RC, Nikolic-Paterson DJ. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int. 2001;60(2):614\u201325.","journal-title":"Kidney Int"},{"issue":"4","key":"5126_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ki.1993.317","volume":"44","author":"K Yoshioka","year":"1993","unstructured":"Yoshioka K, Takemura T, Murakami K, Okada M, Yagi K, Miyazato H, Matsushima K, Maki S. In situ expression of cytokines in IgA nephritis. Kidney Int. 1993;44(4):825\u201333.","journal-title":"Kidney Int"},{"issue":"3","key":"5126_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/ki.1993.98","volume":"43","author":"IL Noronha","year":"1993","unstructured":"Noronha IL, Kr\u00fcger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 1993;43(3):682\u201392.","journal-title":"Kidney Int"},{"issue":"1","key":"5126_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI5535","volume":"104","author":"M Tomana","year":"1999","unstructured":"Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Investig. 1999;104(1):73\u201381.","journal-title":"J Clin Investig"},{"key":"5126_CR30","first-page":"129","volume":"157","author":"H Suzuki","year":"2007","unstructured":"Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol. 2007;157:129\u201333.","journal-title":"Contrib Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05126-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:04:16Z","timestamp":1788876256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05126-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper followed the Helsinki Declaration. The study was approved by the Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Written informed consent was obtained from the patient\u2019s parents for the publication of this case report and any accompanying images.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have obtained written informed consent from the parents of the patient for the publication of clinical details and clinical images.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"530"}}